109 related articles for article (PubMed ID: 25882195)
1. Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin.
Franchin C; Salvi M; Arrigoni G; Pinna LA
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1676-86. PubMed ID: 25882195
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
[TBL] [Abstract][Full Text] [Related]
3. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
[TBL] [Abstract][Full Text] [Related]
4. Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.
Franchin C; Borgo C; Cesaro L; Zaramella S; Vilardell J; Salvi M; Arrigoni G; Pinna LA
Cell Mol Life Sci; 2018 Jun; 75(11):2011-2026. PubMed ID: 29119230
[TBL] [Abstract][Full Text] [Related]
5. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633
[TBL] [Abstract][Full Text] [Related]
6. The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.
Cozza G; Venerando A; Sarno S; Pinna LA
Biomed Res Int; 2015; 2015():734127. PubMed ID: 26558278
[TBL] [Abstract][Full Text] [Related]
7. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
Gyenis L; Turowec JP; Bretner M; Litchfield DW
Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
[TBL] [Abstract][Full Text] [Related]
8. Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.
Gyenis L; Kuś A; Bretner M; Litchfield DW
J Proteomics; 2013 Apr; 81():70-9. PubMed ID: 23017496
[TBL] [Abstract][Full Text] [Related]
9. Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.
Venerando A; Franchin C; Cant N; Cozza G; Pagano MA; Tosoni K; Al-Zahrani A; Arrigoni G; Ford RC; Mehta A; Pinna LA
PLoS One; 2013; 8(9):e74232. PubMed ID: 24058532
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
[TBL] [Abstract][Full Text] [Related]
11. A CE-based assay for human protein kinase CK2 activity measurement and inhibitor screening.
Gratz A; Götz C; Jose J
Electrophoresis; 2010 Jan; 31(4):634-40. PubMed ID: 20162588
[TBL] [Abstract][Full Text] [Related]
12. Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.
Zanin S; Sandre M; Cozza G; Ottaviani D; Marin O; Pinna LA; Ruzzene M
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1694-707. PubMed ID: 25936516
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase CK2 regulates metal toxicity in neuronal cells.
Zaman MS; Johnson AJ; Bobek G; Kueh S; Kersaitis C; Bailey TD; Buskila Y; Wu MJ
Metallomics; 2016 Jan; 8(1):82-90. PubMed ID: 26623569
[TBL] [Abstract][Full Text] [Related]
14. ATP site-directed inhibitors of protein kinase CK2: an update.
Sarno S; Papinutto E; Franchin C; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Orzeszko A; Zanotti G; Battistutta R; Pinna LA
Curr Top Med Chem; 2011; 11(11):1340-51. PubMed ID: 21513497
[TBL] [Abstract][Full Text] [Related]
15. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase CK2 phosphorylates and upregulates Akt/PKB.
Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M
Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.
Schwind L; Wilhelm N; Kartarius S; Montenarh M; Gorjup E; Götz C
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2207-16. PubMed ID: 26025678
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes.
Wilhelm N; Kostelnik K; Götz C; Montenarh M
Mol Cell Biochem; 2012 Jun; 365(1-2):37-45. PubMed ID: 22270543
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase CK2: a newcomer in the 'druggable kinome'.
Pagano MA; Cesaro L; Meggio F; Pinna LA
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1303-6. PubMed ID: 17073807
[TBL] [Abstract][Full Text] [Related]
20. Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells.
Li Q; Zong Y; Li K; Jie X; Hong J; Zhou X; Wu B; Li Z; Zhang S; Wu G; Meng R
Biol Res; 2019 Apr; 52(1):22. PubMed ID: 30992075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
